COVID-19 effect on the research-innovation-commercialisation phenomena
by Alberto Boretti
International Journal of Research, Innovation and Commercialisation (IJRIC), Vol. 3, No. 1, 2020

Abstract: The COVID-19 epidemic and the policy response is disrupting life around the world, with significant impacts also on the economy. This economic downturn will impact R&D expenditure, and therefore, on innovation and commercialisation. Apart from specific sectors that could receive more funds, for example, pharmaceuticals more than health, surveillance and defence, communications, digital markets, and distant education, investments in every other sector are expected to plunge. The opportunity to innovate and commercialise new products, process, or methods in a free market economy is expected to follow the dropping investments.

Online publication date: Fri, 04-Sep-2020

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Research, Innovation and Commercialisation (IJRIC):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com